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ABSTRACT 
Background and Purpose: Individuals who have experienced a pyramidal cerebrovascular 
accident (pCVA) often exhibit impairments to volitional control of corresponding motor tasks. 
Promising effects in motor response, post-application of transcranial direct current stimulation 
(tDCS), have been reported in studies on individuals with the ability to achieve independent gait 
for 20 minutes. These studies mainly examined the effects of combined tDCS with locomotor 
training on lower extremity function among higher functioning individuals post-stroke. The 
purpose of this study was to determine the effect of tDCS among individuals post-stroke who 
may not have independent ambulatory capabilities, focusing on motor response and less 
demanding outcomes. The results of this study will extend knowledge on tDCS effects among 
lower functioning individuals post-CVA. 
Methods: Four individuals with chronic stroke (2.38  ± 0.63 years) randomly received either 
cathodal stimulation or a sham treatment to their non-lesioned hemisphere. Transcranial 
magnetic stimulation (TMS) was used in order identify the tibialis anterior hotspot in the motor 
cortex of their lesioned hemisphere such that we were able to assess and reassess the effects of 
tDCS at the same hotspot location. Fourteen days later, subjects attended a second session where 
they received the intervention that they did not receive in the first session (either sham or 
cathodal tDCS). Lower extremity (LE) function was evaluated by comparing pre and post 
intervention Timed Up and Go (TUG) scores, as well as Step Length, Stride Length, Stride 
Width, Stance Time, Swing Time, Gait Velocity, Ambulation Time, and Cadence. Motor 







Results: There was a statistically significant change in the MEP value measured before and after 
cathodal tDCS compared to sham (p = 0.037 < 0.05). There was no statistically significant 
difference when comparing tDCS to sham interventions for: resting motor threshold maximum 
stimulator output (rMT MSO%), TUG, Step Length, Stride Length, Stride Width, Stance Time, 
Swing Time, Gait Velocity, Ambulation Time, and Cadence. 
Discussion: For those who are living post-stroke, the application of cathodal tDCS may provide 
a relative increase in cortical excitability of the ipsilesional hemisphere. Future tDCS research 
should incorporate functional interventions to see if they can promote lasting effects. 	
v	
ACKNOWLEDGEMENTS 
This research study was made possible by the University of Nevada, Las Vegas 
Physical Therapy Student Opportunity Research Grant. The Authors would like to thank 
Jing Nong Liang, PT, PhD. for her excellent guidance as principal investigator of this 
study. The authors would also like to thank Szu-Ping Lee and Hui-Ting Shih for their 
additional help with this project.  
vi	
TABLE OF CONTENTS	
Abstract ......................................................................................................................................... iii 
Acknowledgements .........................................................................................................................v 
List of Tables ................................................................................................................................ vii 







Curriculum Vitae ...........................................................................................................................22 
vii	
LIST OF TABLES 
Table 1. Subject Demographics .....................................................................................................12 
Table 2. Change in TMS and Gait Variables and Effect Significance of that Change based on 
Intervention Groups .......................................................................................................................12 






LIST OF FIGURES 
Figure 1 TA Electrode .....................................................................................................................7 
Figure 2 Sideview Electrode ............................................................................................................7 
Figure 3 Soleus Electrode ................................................................................................................7 
Figure 4 Camera ...............................................................................................................................7 
Figure 5 Pointer ................................................................................................................................7 
Figure 6 3D Markers ........................................................................................................................8 







Stroke is a brain lesion that often affects neuromuscular control, impairing the ability of 
the brain to generate and transmit motor signals from the motor cortex, through the corticospinal 
circuitry, to the intended muscles16. In a non-impaired nervous system, this particular descending 
group of nerves from the motor cortex carries the signals for voluntary movement of the 
peripheral muscles12. For those with a stroke lesion, the signals are disrupted, and voluntary 
motor control is impaired. One barrier to recovery stems from the imbalance of cortical 
excitability between the two brain hemispheres, with the lesioned hemisphere having decreased 
excitability compared to the non-lesioned hemisphere. This imbalance of cortical excitability is 
associated with functional impairments14.  
A key concept in the rehabilitation of brain injuries is neuroplasticity, which can be 
described as the brain’s ability to adapt and create new neuronal connections in response to 
injury14. Progressively challenging a patient’s fine and gross motor control of muscles on their 
affected side leverages these neuroplasticity principles. This type of training helps stimulate the 
brain to reorganize and improve neuronal connections, and thereby improve transmission of 
motor signals6. While these conventional treatments can provide improvements in motor control 
for patients post-stroke, there has been recent research examining the benefits of supplementing 
treatments with neuromodulation5, 9,11.  
Neuromodulation consists of either invasive or noninvasive stimulation of the nervous 
system through electrical or chemical approaches23. Modulating cortical excitability using non-
invasive neuromodulation techniques has been associated with improved motor performance, 
such as walking, in neurologically impaired individuals5. Modulation of cortical excitability can 






tDCS is a form non-invasive electrical stimulation in which low-intensity electrical stimulation is 
applied to a targeted area of the brain in order to elicit neuronal responses in the distal motor 
units of the corticospinal tract. Single pulse transcranial magnetic stimulation (TMS) is another 
form of noninvasive brain stimulation that can be used in conjunction with tDCS as a tool to 
excite the corticospinal tract and elicit a motor evoked potential (MEP) of a targeted muscle24. 
Using a device such as TMS compared to participant volitional contraction of the tibialis anterior 
muscle allows the researchers to apply a stimulus that is of proportionately equal intensity 
amongst all participants. 
When applied to the contralesional hemisphere (the hemisphere that does not contain a 
lesion), cathodal tDCS has been shown to have an inhibitory effect on motor excitability and is 
best used on the contralesional hemisphere in order to decrease interhemispheric inhibition, 
resulting in a relative increase in excitability in the affected hemisphere4, 9,11. In contrast, anodal 
tDCS applied to the ipsilesional hemisphere (the hemisphere that contains the lesion) has been 
shown to have an excitatory effect on motor excitability5. Emerging research using anodal 
stimulation is suggestive that it is best utilized over the ipsilesional hemisphere in order to 
increase that hemisphere’s ability to transmit motor signals from the cortex to the intended 
peripheral muscle by increasing cortical excitability7, 9. This modulation of excitability allows for 
a restoration of balance between the two hemispheres and has led to functional improvement20, 26. 
When applied individually, anodal and cathodal tDCS have been shown to change 
corticomotor excitability in resting subjects. The study by Fregni et al demonstrated an 
improvement in hand motor function after the application of cathodal tDCS (applied to the 
unaffected motor cortex) and anodal tDCS (applied to the affected motor cortex)9. This effect has 






functional task such as walking on a treadmill, anodal and cathodal tDCS facilitates transient 
increases in lower extremity extensor force and fine motor control within a single session6. 
Functional outcomes and corticomotor excitability are greater when tDCS and functional training 
are used together compared to anodal or cathodal tDCS alone11.  
Previous studies examining tDCS combined with locomotor training have been limited to 
patients who could walk continuously for 20 minutes at a time, or without an assistive device, 
but these high functioning individuals are not representative of the entire stroke community5. 
Many individuals with chronic stroke are limited in activities such as ambulation due to muscle 
impairments, requiring greater energy expenditure in performance. Therefore, many of these 
patients don’t have the endurance to ambulate for 20 minutes at a time. The purpose of our study 
was to test the effect of cathodal tDCS on lower functioning individuals, with a protocol 
requiring minimal walking, to determine the potential benefit to this population.  
 
Aim 1: To determine the effects of cathodal tDCS over contralesional motor cortex on the 
corticospinal excitability of paretic tibialis anterior (TA).   
Hypothesis 1: Cathodal tDCS over the contralesional motor cortex will result in increased 
excitability of ipsilesional cortex as measured by MEP of the paretic tibialis anterior muscle. 
Aim 2: To examine the functional outcomes associated with inhibition of contralesional motor 
cortex using the Timed-Up and Go (TUG) test, and gait variables (stride length, stride width, 
stance time, swing time, velocity, ambulation time, and cadence).  
Hypothesis 2: Cathodal tDCS over the contralesional motor cortex will improve functional 








A sample of 14 individuals was calculated in order to have 95% power at an α value of 0.05 for a 
two-sided paired t-test. Inclusion criteria included diagnosis of a cortical and/or subcortical 
lesion and ability to perform a TUG test with or without us of an assistive device. Exclusion 
criteria included contraindications to TMS or tDCS (metallic implants, history of seizure, and 
use of medications known to alter central nervous system excitability), those confined to a 
wheelchair, and anyone under the age of 18 years29. The protocol was approved by UNLV's 
Institutional Review Board.  
Instrumentation 
A Magstim 200 stimulation (Magstim,UK) via a double cone coil was used to apply 
TMS. A stereotactic image guidance system (Brainsight, Rogue Research Ic) was used to guide 
the site of TMS application. tDCS was delivered through a constant current stimulator via an 8 
cm2 oblong saline-soaked sponge cathode placed over the non-lesioned primary motor cortex 
(M1) for the leg. A carbonized reference anode was placed on the forehead above the 
contralateral orbit. Surface electromyography (EMG) (Bagnoli, Delsys Inc., Natick, MA) was 
used to measure the muscle activity from the tibialis anterior and soleus muscles of the affected 
limb. The SIGNAL (Cambridge Electronic Design Limited, UK) computer program was used to 
collect numerical data after each TMS pulse was applied. The Zeno Mat (ProtoKinetics LLC, 
PA), a walkway gait analysis mat, in combination with its ProtoKinetics Movement Analysis 
Software (PKMAS), was used to assess gait function by measuring stride length, stride width, 






was performed once with each participant, which is an assessment tool used specifically for 
individuals post stroke to determine motor and sensory function, balance, joint range of motion, 
and joint pain10. The maximum score for the motor function portion of the LE Fugl-Meyer is 34, 
indicating no impairment in motor function. The Timed Up and Go test (TUG) was also 
administered in order to determine lower extremity functional mobility by having participants 
ambulate a self paced 3 meters before and after each treatment session21.  Many individuals who 
have suffered from a stroke suffer from gait deficits that greatly reduce their ambulation speed, 
increasing their risk for falls and diminishing their safety. The TUG is a useful outcome measure 
to examine a participant’s functional mobility in a community setting and will be useful in 
assessing if application of cathodal tDCS will improve participant ambulation and transfer 
speed27. 
Procedure 
Participants came to the research lab where informed consent was obtained. Subjects then 
signed a screening form, which detailed the inclusion and exclusion criteria to the study. Data 
collection occurred on two separate days with at least 14 days between the two sessions. Sessions 
were scheduled for approximately the same time of day and we requested that participants 
followed similar routines on both days. On the first day of data collection, the participants 
performed two different tests: the lower extremity Fugl-Meyer, and the TUG performed on the 
Zenomat, where gait parameters will also be collected for time conservation. Although the TUG 
and the Zenomat assess different variables, the TUG will be performed on the Zenomat in order 
to maximize the number of variables that will be measured in a period of time, therefore 
decreasing the amount of time the participant spends with the research team, keeping in mind 






Next, with the participant standing, the skin above the bellies of the tibialis anterior and 
soleus affected by the stroke was shaved, cleaned, and exfoliated with rubbing alcohol swabs. 
Shaved areas were limited to twice the size of the electrode. The EMG sensors were then placed 
on the prepared skin [Figures 1 & 3], and the ground electrode was placed over the lateral 
malleolus. If the participant was able to volitionally contract the tibialis anterior muscle, they 
were asked to perform an isometric contraction of the tibialis anterior, lifting the toes into one of 
the researcher’s hand, and the researcher would palpate the muscle belly for electrode placement. 
For the soleus, the participant would perform a concentric contraction by standing on their toes, 
and the researcher would feel for the lateral gastrocnemius muscle head. Keeping the 
researcher’s fingers just distal to the head, the participant would then bend their knee and point 
their toes into the floor, and the researcher would find the bulk of the belly just distal and lateral 
head of the gastrocnemius. The same researcher performed electrode placement each session. 
If there was difficulty finding the subject’s muscle bellies, the tibialis anterior was instead 
found by creating an imaginary line between the ipsilateral tibial tuberosity and the 
intermalleolar line (referred to as the anatomical landmark frame, or ALF), and then placing the 
electrode at 20% of the ALF, just distal to the tibial tuberosity. For the soleus, the ALF was 
created between the medial side of the Achilles tendon insertion and the head of the fibula. The 
electrode was placed just proximal of the insertion of the Achilles at about 30%. Pictures of the 
sensor locations were taken to ensure consistent placement across sessions. 
The participant was then seated in a chair with the affected leg supported and strapped 
into a footplate to keep his or her foot in a neutral dorsiflexed position.  One of the researchers 
placed a band around the participant’s head that contained a marker that is detected by a camera 






used to determine the brain “hotspot” which is the region of the motor cortex that consistently 
elicits the largest MEP of the targeted tibialis anterior muscle when TMS is applied23. The 
Brainsight Neuronavigation System provides a human brain template, created from the average 
of 25 different brain MRI scans. In combination with the template, 3D markers [Figure 6] were 
placed near the participant’s skull. A camera [Figure 4] was used to detect the markers in space 
in order to create a 3D model brain similar in size and shape to the subject’s brain. 
 
Figure 1.TA Figure 2. Side view	 Figure 3. Soleus 







A pointer [Figure 5] was used in combination with the camera to identify five key areas 
on the subject’s skin: one over the nasion, one on the lateral portion of each orbit, and one 
antero-superior to the tragus of each ear. Then, a series of 30+ measurements were taken to 
establish accurate dimensions of the subject’s skull circumference. These measurements record 
the most lateral, most superior, most anterior, and most posterior portions of the cranium to 
obtain an accurate representation of the subject’s skull in 3D space that was reconstructed and 
used as our model on the Brainsight software. 
After the model of the participant’s brain was generated, the suprathreshold Machine 
Simulated Output (MSO) value of the affected tibialis anterior muscle was found. The 
suprathreshold is considered to be the minimum stimulus required to obtain a MEP with > 50 
mV peak to peak amplitude over several attempts. The MSO is the output value indicated on the 
TMS device. This number can be adjusted up and down to identify the intensity required to 
confirm the suprathreshold. In order to find the suprathreshold MSO, the location of M1 was 
estimated by identifying a virtual line of connection from the superior aspect of the skull to the 
tragus of the ear on the side of the affected hemisphere. This area was confirmed by comparing 






the Brainsight grid of the M1 to the target representing the TMS double coil. A series of TMS 
pulses at varying MSO values were given until the EMG reading on the SIGNAL software 
(Cambridge Electronic Design Limited, England) demonstrated consistent motor evoked 
potentials (MEPs) of the affected tibialis anterior and soleus greater than 0.05 mV within the M1. 
Once the suprathreshold MSO was determined, an 8x4 grid constructed by Brainsight 
was placed over the affected motor cortex of the model on the software, indicating to the 
researchers the location of each spot for TMS stimulation on the actual brain. The grid was 
constructed of 32 different locations, and using the TMS coil, each spot was stimulated while the 
corresponding MEP amplitudes were recorded using SIGNAL. The coil contained a 3D marker 
that allowed the Brainsight camera to determine its location in comparison to the participant’s 
brain, and this allowed for accurate stimulation of each spot in the grid. The hotspot was 
determined by the location that elicited the highest MEP amplitude at the given supramaximal 
stimulus level. 
The hotspot was then used to determine the resting motor threshold (rMT) using the 
Parameter Estimation by Sequential Testing (PEST) procedure provided within the software 
TMS Motor Threshold Assessment Tool (TMS MTAT 2.0) 3. This also involves using SIGNAL 
software to observe for an EMG reading greater than 0.05 mV. PEST generated the MSO of the 
rMT through the use of an algorithm, which refined the minimum TMS output percentage that 
was strong enough to elicit a reading greater than 0.05 mV. 
Once the above steps were completed, a series of TMS pulses at varying MSOs were 
applied to the hotspot until the EMG reading on the SIGNAL software demonstrated consistent 






minimum number of pulses and maintain subject comfort, the MSO of the suprathreshold 
previously obtained was increased by increments of 2%, until the desired level was achieved. 
Participants received either cathodal tDCS or sham treatment for 20 minutes and in the 
second session received the other, such that at the end of their second session they had 
experienced both sham and tDCS. The treatment that they received during the first session was 
determined randomly, and they received the other treatment during their second session. Only 
one of the researchers knew which treatment the patient received and that researcher was not 
involved in data collection. The remaining personnel involved were blinded to the intervention 
group.  
tDCS strength was set at 0.06 mA/cm2. The electrical field was oriented with the 
stimulation electrode at the M1 leg area of the affected cortex and the reference electrode placed 
on the contralateral orbit20. The participant had his or her foot strapped with Velcro to a force 
plate set at 0˚ neutral dorsiflexion. With visual feedback, the participant activated the TA muscle 
at 20% maximal TA EMG activity at a consistent rate isometrically (2 second contraction, 2 
second relax), set by a metronome at 30 Hz throughout the 20 minutes of tDCS application. After 
20 minutes, the tDCS or sham treatment was removed and we assessed the post-test MEP values 
at 120% rMT.  
The participant performed the TUG on the Zenomat as they did at the beginning of the 
session, starting with using PEST to determine the MSO of the rMT. However, for the second 
outcome measure regarding the MSO MEP, we utilized the same MSO that produced and 
average of 0.1 mV previously and stimulated the person’s brain only ten times to find the new 
average of the ten readings. Then, the participant was disconnected from the EMGs and was 







IBM SPSS for Windows Version 24.0 was used to perform all statistical analyses. 
Descriptive statistics included mean and standard deviation of each variable were calculated 
based on time (pre/post intervention) and intervention type (cathodal tDCS/sham). A 2 x 2 
repeated measures ANOVA was used to determine association between the intervention type, 
time, and the interaction between intervention type and time. Appropriate post-hoc analysis was 
then used to determine differences in pairwise comparisons. Statistical significance was defined 
as P < 0.05. 
RESULTS 
 
 Four participants with chronic post-stroke hemiparesis completed the study.  Participant 
characteristics are presented in Table 1. 
For the MEP, there was no statistically significant interaction found for time and 
condition (F(1,3)=0.810, p=0.43). There was no statistically significant difference found for 
condition (F(1, 3)=1.48, p=0.31).  There was a statistically significant difference found for time 
(F(1, 3)=12.79, p=0.04).  Simple main effect analysis using paired samples T-Test showed that 
following cathodal stimulation, MEP amplitudes were higher (0.34mV±0.20) compared to before 
stimulation (0.24±0.12) (p=0.02).  In contrast, following sham stimulation, MEP amplitude did 
not change (0.24±0.43) compared to before stimulation (0.25±0.16) (p=0.74). 
 For the rMT, TUG, Step Length, Stride Length, Stride Width, Stance Time, Swing Time, 
Gait Velocity, Ambulation Time, and Cadence, the 2 way ANOVA revealed no significant 
interaction between condition and time and there were no statistically significant differences 








Table 2: Change in TMS and Gait Variables and Effect Significance  
of that Change based on Intervention Groups 
Variable 









tDCS 50.25+9.60 51.75+9.18 1.5 tDCS: 0.83 
  Sham 51.00+10.10 49.75+9.71 -1.25 Time: 0.95 
      Time x 
tDCS: 
0.151 
 MEP (mV) tDCS 0.240+0.119 0.341+0.204 0.101 tDCS: 0.311 
  Sham 0.254+0.163 0.241+0.430 -0.013 Time: 0.037 





TUG (sec) tDCS 10.93+1.77 10.85+1.65 -0.08 tDCS: 0.412 
  Sham 12.26+3.42 11.33+2.05 -0.93 Time: 0.324 
      Time x 
tDCS: 
0.289 
 Step Length 
(cm) 
tDCS 50.65+4.82 52.74+3.97 2.09 tDCS: 0.328 
  Sham 49.07+7.21 49.08+5.30 0.01 Time: 0.406 





tDCS 102.68+10.30 102.56+8.91 -0.12 tDCS: 0.437 
Table 1: Subject Demographics 
Age (yr) 63.50+6.75 
Lesion Side (L|R) 4|0 
Time Post Stroke (yr) 2.38+0.63 






  Sham 96.81+15.51 99.08+12.01 2.27 Time: 0.346 





tDCS 12.13+4.60 12.97+3.07 0.84 tDCS: 0.879 
  Sham 12.63+4.99 12.85+3.34 0.22 Time: 0.583 
      Time x 
tDCS: 
0.747 
 Stance Time 
(sec) 
tDCS 0.864+0.097 0.854+0.066 0.01 tDCS: 0.648 
  Sham 0.872+0.124 0.824+0.068 -0.048 Time: 0.374 
      Time x 
tDCS: 
0.528 
 Swing Time 
(sec) 
tDCS 0.469+0.138 0.472+0.117 -0.042 tDCS: 0.734 
  Sham 0.428+0.089 0.447+0.102 0.019 Time: 0.591 






tDCS 76.01+7.52 82.15+11.66 6.14 tDCS: 0.558 
  Sham 75.18+19.59 77.04+13.03 1.86 Time: 0.261 





tDCS 6.89+1.28 6.30+1.01 -0.59 tDCS: 0.278 
  Sham 7.51+1.53 7.13+1.53 -0.38 Time: 0.1 





tDCS 90.35+13.16 97.13+11.45 6.78 tDCS: 0.979 
  Sham 93.07+12.02 94.48+9.38 1.41 Time: 0.21 


















 We found that the MEP amplitude of the affected tibialis anterior muscle was 
significantly improved in those who received cathodal tDCS intervention, while there was no 
improvement for those who had the sham treatment. This indicates a relative increase in 
excitation of the corticospinal tract of the lesioned side due to inhibition of the contralesional 


















Figure 7. Comparison of MEP value prior 
to and following tDCS intervention
Table 3: MEP Change Pre and Post Intervention 
 Pre-Intervention MEP (mV) Post-Intervention MEP (mV) P value 
tDCS 0.240 ± 0.119 0.341 ± 0.204 0.016 
Sham 0.254 ± 0.163 0.241 ± 0.430 0.735 






implications for future rehabilitation of an individual chronic post-stroke. Individuals with 
chronic stroke have passed the traditional “therapeutic window” in which neuroplasticity 
training is known to be most fruitful14. By inhibiting the contralesional hemisphere with 
cathodal tDCS there is an opportunity for the individual to perform rehabilitative interventions 
focused on increasing strength, endurance, and coordination in lower extremity musculature via 
changes in the corticospinal tract excitation8. This process allows the ipsilesional hemisphere to 
regain greater influence over the ipsilateral corticospinal tracts4, 6. This in turn can allow the 
ipsilesional hemisphere to become effectively stronger and more influential regarding the 
control of signals through the corticospinal tract due to increased communication from the 
affected motor region in the hemisphere to the tibialis anterior muscle and therefore increased 
rehabilitation potential6, 11. 
 Although not statistically significant, there was a trend toward increased gait velocity in 
subjects that got tDCS treatment, although step length, stride length, stride width, and cadence 
did not seem to be affected. However, we cannot be sure if the application of cathodal tDCS is 
responsible for the trending increase in gait velocity, or if there was a learning effect from 
repeatedly performing the TUG. Despite, the TUG being a quick and simple test, reliable for 
quantifying change over time in older adult populations, a learning effect is still important to 
consider21.  
 There are several possible explanations for why we did not find significant associations 
between our outcomes and tDCS application. One is that we were unable to recruit 14 
participants, and in fact only recruited 4, leaving the study underpowered. It is likely that we 
were unable to detect actual effects given this small sample. Another reason may be due to 






effect of cathodal tDCS on the upper extremities or focus more on the effects of anodal tDCS 
stimulation over the affected hemisphere. Jeffery et al. discussed how anodal stimulation has 
depolarizing effects, allowing for greater corticospinal tract conductivity, whereas cathodal tDCS 
has a hyperpolarizing affect. They noted that hyperpolarizing stimulation of the lower extremity 
compared to the upper extremity with equivalent currents had a minimal effect on the amplitude 
of measured MEPs recorded both at rest and during contraction of the tibialis anterior muscle13. 
This suggests that it is more difficult to suppress the excitability of the leg motor cortex 
compared to the hand motor cortex with cathodal tDCS due to fewer available inhibitory circuits 
compared to the hand motor cortex. Although we were not trying to suppress the excitability of 
the involved hemisphere, it is still possible that it makes suppressing the uninvolved hemisphere 
more difficult as well, making a large impact less possible and reducing the influence from the 
healthy cortex. 
Although our goal was to recruit lower functioning patients, our participants were rather 
high functioning, even after having experienced a stroke. Several of our patients exercised 
regularly and were self-reported community ambulators. Our high functioning sample does not 
allow us to determine if step length, stride length, stride width, or cadence were improved by 
tDCS because they were not impaired to begin with. Chang et al tested anodal tDCS effects to 
see if application could not only increase cortical excitability but also lower limb motor function. 
They discovered that although there was some recovery of lower limb weakness with application 
of anodal tDCS, the amount of recovery was not enough to improve function in standing or gait5. 
However, they suggested that tDCS could be used as an adjuvant therapeutic modality to assist 
with improving lower limb motor function. We had similar results as Basanti et al, who 






individuals and those affected by stroke. Their review concluded that the evidence supports 
induced MEP with TMS and a tDCS intervention increases peak-to-peak MEP amplitude, 
indicating an increase in corticospinal tract excitation in both healthy and individuals affected by 
stroke. However, they did not see evidence for significant effects in motor function 
improvements for people with or without stroke2. Our study suggests that there may be a 
particular level of functional mobility deficits at which tDCS has its greatest impact on 
rehabilitation potential. Future studies should examine whether or not a specific level of 
functional mobility exists at which improvement with tDCS can be observed.  
It is also important to note that another potential increase in MEP amplitude could have 
been due to performing isometric exercise during the session. EMG signals, and therefore MEP 
amplitudes, increase during sustained sub-maximal voluntary contraction, especially towards the 
end of a contraction25. Therefore, we can’t determine if our participants increase in MEP was 
created solely by the application of tDCS, if their isometric dorsiflexion activity while receiving 
the tDCS, or a combination affected their MEP change.  
Interestingly enough, many participants said they felt better the day after receiving 
treatment. Three of our subjects stated that they felt that they could walk better the next day and 
for a few days following their participation. We did not take measurements in the days following 
treatment so we cannot know the extent or reality of these reports. Additionally, there is high 
potential for placebo to account for the subjects’ experience. It may be beneficial in future 
studies to collect data immediately after and then 24 hours after tDCS application. Another 
option for future studies would be to include patient reported outcomes. Chang et al. had 
measured the effects of anodal stimulation 24 hours post application and found that corticospinal 






increases in Fugl-Meyer scores as well as scores for the Lower Limb Motricity Index. They also 
discovered a trend for greater changes within the Functional Ambulatory Category with those 
who received anodal stimulation versus the sham5. Additionally, future work should consider the 
effects of tDCS on MEP with multiple applications as larger increases may be seen with more 
consistent application due to a cumulative effect1. 
Another implication for future research would be to examine the effects of cathodal tDCS 
on multiple lower extremity muscles. Our study only looked at the effects of cathodal tDCS on 
the tibialis anterior muscle, yet we looked at complete gait cycle outcomes. Other important 
muscles responsible for smooth gait, such as the quadriceps, gastrocnemius, and hamstrings, 
could be impacted by the use of tDCS28. Seeing that the MEP increased in the corticospinal tracts 
for tibialis anterior, it is likely that the corticospinal tracts of other lower extremity muscles were 
also positively affected. A study by Tanaka et al provides evidence that tDCS can be used to 
improve force produced by a paretic quadricep, therefore increasing the participant’s ability to 
extend their knee28. Future research should consider therapeutic interventions to multiple 
muscles of the leg and other impairments, such as lack of hip extension or knee extension 
strength.   
CONCLUSION 
This study examined the effect of cathodal tDCS over the contralesional M1 area 
responsible for the tibialis anterior. Our subjects experienced a statistically significant increase in 
MEP when they received tDCS and no change when they received sham. However, there was no 
change in gait or TUG. Future studies should examine the effect of cathodal tDCS on individuals 
post-stroke with a variety of functional abilities, consider other muscles, and examine effects 
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